Afficher la couverture 'Quality-of-care indicators for oncology management : an analysis of Asia-Pacific healthcare and oncology indicators | KANESVARAN, R.' en grand format
/5

0 avis

Quality-of-care indicators for oncology management : an analysis of Asia-Pacific healthcare and oncology indicators

Article

KANESVARAN, R. | WONG, E. Y. T. | KEAM, B. | PRASONGSOOK, N. | MALHOTRA, H. | BLAY, J.-Y.

Cancer is a major cause of morbidity and mortality, with variable outcomes seen in the Asia-Pacific region due to substantial differences in cancer care and management. Quality indicators are evidence-based, standardized measures of healthcare quality that help measure or quantify healthcare processes, outcomes, and organizational systems to help promote and provide equitable high-quality healthcare. A detailed list of quality indicators in medical, surgical, and palliative oncology was identified from literature reviews. This study, which was commissioned by the ESMO Asia Pacific Public Policy Committee, aims to report on the performance of healthcare and oncology quality indicators across 47 countries in the Asia-Pacific region.

http://dx.doi.org/10.1016/j.esmoop.2025.104293

Voir la revue «ESMO open, 10»

Autres numéros de la revue «ESMO open»

Consulter en ligne

Suggestions

Du même auteur

Quality-of-care indicators for oncology manag...

Article indépendant | KANESVARAN, R. | ESMO open | n°3 | vol.10

Cancer is a major cause of morbidity and mortality, with variable outcomes seen in the Asia-Pacific region due to substantial differences in cancer care and management. Quality indicators are evidence-based, standardized measures ...

Quality-of-care indicators for oncology manag...

Article indépendant | KANESVARAN, R. | ESMO open | n°3 | vol.10

Cancer is a major cause of morbidity and mortality, with variable outcomes seen in the Asia-Pacific region due to substantial differences in cancer care and management. Quality indicators are evidence-based, standardized measures ...

Globalization of clinical trials in oncology ...

Article | IZARN, F. | ESMO open | n°1 | vol.10

BACKGROUND: Over the past two decades, the globalization of oncology clinical trials has expanded, yet significant disparities persist across countries. This study aimed to evaluate these geographical inequalities, the evolution o...

De la même série

Globalization of clinical trials in oncology ...

Article | IZARN, F. | ESMO open | n°1 | vol.10

BACKGROUND: Over the past two decades, the globalization of oncology clinical trials has expanded, yet significant disparities persist across countries. This study aimed to evaluate these geographical inequalities, the evolution o...

A taxonomy of the factors contributing to the...

Article | CHERNY, N. I. | ESMO open | n°1 | vol.10

Many patients with cancer approaching the end of life (EOL) continue to receive treatments that are unlikely to provide meaningful clinical benefit, potentially causing more harm than good. This is called overtreatment at the EOL....

Health networking on cancer in the European U...

Article | CASALI, P. G. | ESMO open | n°2 | vol.10

Health networking is in principle a formidable instrument to address many challenges posed by cancer, one of the two most common and most lethal non-communicable chronic diseases. The European Union (EU)'s Beating Cancer Plan fore...

Quality-of-care indicators for oncology manag...

Article | KANESVARAN, R. | ESMO open | n°3 | vol.10

Cancer is a major cause of morbidity and mortality, with variable outcomes seen in the Asia-Pacific region due to substantial differences in cancer care and management. Quality indicators are evidence-based, standardized measures ...

Aggressive anticancer treatment in the last 2...

Article | GOLOB, N. | ESMO open | n°3 | vol.9

BACKGROUND: There is a concern that terminally ill cancer patients may be aggressively treated due to the rapidly growing possibilities of anticancer treatment. The aim of this study was to evaluate the use of anticancer treatment...

Chargement des enrichissements...